Guerbet Displays New Multi-Use Injector at ECR 2019
|
By HospiMedica International staff writers Posted on 27 Feb 2019 |
|
Image: The OptiVantage multi-use injector for CT diagnosis (Photo courtesy of Guerbet).
Guerbet (Villepinte, France), a global specialist in contrast media and solutions for diagnostic and interventional imaging, introduced an innovative method to introduce the company’s new strategies and products to delegates at the European Congress of Radiology (ECR) 2019. Using a novel presentation concept developed in collaboration with the European Society of Radiology (ESR), the company enriched the visitors’ experience through a unique combination of integrated solutions and related educational program.
ECR visitors had the opportunity to explore the many Guerbet solutions that apply throughout the whole patient pathway: with contrast media and injection systems, including the new multi-patient solution: OptiVantage multi-use injector for CT diagnosis, and follow-up which answers market needs without compromising efficiency and patient safety. Launched in 2005, the OptiVantage injector is intended for use by medical imaging and diagnostic health professionals, for injecting radiopaque contrast media and saline into a patient’s vascular system during CT examinations. The new version is adapted to multi-use markets and is available in pedestal and ceiling-mount versions.
Guerbet also displayed its digital solutions, featuring Contrast&Care 2.0, a contrast media injection management solution aiming to improve both productivity of healthcare professionals and patient safety. Contrast&Care enables imaging centers to collect, archive, examine and share injection data, including data on contrast media, adverse events, injector activity, information on the estimated glomerular filtration rate (eGFR) and other risk factors before an exam. Contrast&Care 2.0 connects with all CT, Cath Lab and MRI injectors in the current Guerbet range.
Additionally, Guerbet also provided a comprehensive educational program with workshops and a symposium covering hot topics in modern diagnostic radiology such as AI, Gadolinium and brain deposition, contrast optimization, etc., as well as in interventional imaging (cTACE and liver imaging).
ECR visitors had the opportunity to explore the many Guerbet solutions that apply throughout the whole patient pathway: with contrast media and injection systems, including the new multi-patient solution: OptiVantage multi-use injector for CT diagnosis, and follow-up which answers market needs without compromising efficiency and patient safety. Launched in 2005, the OptiVantage injector is intended for use by medical imaging and diagnostic health professionals, for injecting radiopaque contrast media and saline into a patient’s vascular system during CT examinations. The new version is adapted to multi-use markets and is available in pedestal and ceiling-mount versions.
Guerbet also displayed its digital solutions, featuring Contrast&Care 2.0, a contrast media injection management solution aiming to improve both productivity of healthcare professionals and patient safety. Contrast&Care enables imaging centers to collect, archive, examine and share injection data, including data on contrast media, adverse events, injector activity, information on the estimated glomerular filtration rate (eGFR) and other risk factors before an exam. Contrast&Care 2.0 connects with all CT, Cath Lab and MRI injectors in the current Guerbet range.
Additionally, Guerbet also provided a comprehensive educational program with workshops and a symposium covering hot topics in modern diagnostic radiology such as AI, Gadolinium and brain deposition, contrast optimization, etc., as well as in interventional imaging (cTACE and liver imaging).
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Medical-Grade Display
HL2316SHTB
New
Monitor/Defibrillator
Zenix
Latest ECR 2019 News
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
